Catalent
CTLT
#1825
Rank
C$16.24 B
Marketcap
C$89.50
Share price
0.00%
Change (1 day)
17.60%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): C-$8.56

According to Catalent's latest financial reports the company's current EPS (TTM) is C-$8.92. In 2023 the company made an earnings per share (EPS) of C-$9.59 a decrease over its 2022 EPS that were of C$3.20.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$8.56-10.73%
2023C-$9.59-399.56%
2022C$3.20-30.58%
2021C$4.6179.67%
2020C$2.57114.12%
2019C$1.20-15%
2018C$1.4175.44%
2017C$0.80-22.97%
2016C$1.04-59.56%
2015C$2.58282.05%
2014C$0.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
C-$0.72-91.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$0.65-107.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
C-$1.06-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
C-$2.09-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA